Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen Shutters QDC s Hayward Facility, Will Lay Off Substantial Number; Shares Dive 13.3 Percent

NEW YORK , Oct. 28 (GenomeWeb News) - Invitrogen is closing the Hayward, Calif.-based headquarters of  Quantum Dot, which it is in the process of acquiring, and will lay off and possibly relocate the majority of the employees there, the company said yesterday in a conference call highlighting its third-quarter earnings.

 

Invitrogen CEO Greg Lucier said that "we are closing down the Hayward facility where they were located. We've had to do a substantial termination of employees and potential relocation of people to Eugene, Oregon, to the Molecular Probes campus."

News of the lay-offs accompanied Invitrogen's report of a 13-percent jump in third-quarter revenues. The company failed to meet Wall Street earnings estimates and internal revenue targets, however, which caused shares in the Carlsbad, Calif.-based company to plummet 13.29 percent, or $9.41, to $61.37 in mid-afternoon trading today.

 

Eric Endicott, an Invitrogen spokesperson, said the company will wrap up the lay-offs by the end of the year. As of Friday afternoon, an operator was still answering general phone calls at Quantum Dot.

 

Quantum Dot has around 55 employees, Endicott said, though he wasn't able to say how many of that number would be laid off.

 

Invitrogen announced plans to acquire Quantum Dot earlier this month, although the company hasn't officially closed the acquisition. Terms of the deal have not been disclosed.

 

A complete version of this article will appear in this week's issue of Cell-Based Assay News, a GenomeWeb News sister publication.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.